Developing new treatment regimens for HIV
European Pharmaceutical Review
MARCH 11, 2024
With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety. Prior to joining ViiV, she served at an industry position with Roivant Sciences as Vice President of Clinical Research, where she managed the Rare Diseases portfolio. References 1. Internet] 2023.
Let's personalize your content